-

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center and the International Society of Gastrointestinal Oncology. Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Medical_Professionals
• Medical_students
• Nurses

The conference will feature distinguished speakers covering a broad spectrum of topics ranging from basic science to clinical therapeutics. Presenters and discussants will explore current issues and debate controversial topics. Case presentations will be given by the faculty and the audience will participate by an interactive audience response system to stimulate discussion on diagnosis and management. This program should be of interest to professionals actively engaged clinically or scientifically in all facets of GI cancer research and care, including oncologists, surgeons, radiologists, general scientists, fellows, young investigators, nurses and pharmacists.

Educational Objectives

After attending this activity, the participant will demonstrate the ability to:

bIdentify recent advances and innovations in the treatment of GI malignancies within the past 12 months

bDescribe emerging evidence from current clinical trials that may impact treatment decision making in GI oncology

bFormulate a multi-modal approach to the treatment of GI cancers including Gastric, HCC, Cholangiocarcinoma, Pancreatic and Colorectal Cancers

bAnalyze how recent clinical trial data demonstrate a significant survival benefit with a combination chemotherapy regimen in patients with metastatic pancreatic cancer

bAssess how new developments in treating advanced pancreas adenocarcinoma may help guide post surgical treatment strategies

bDefine which patients will benefit from sequencing strategies of anti-EGFR and anti-VEGF therapies, for all patients with normal KRAS, regardless of BRAF status (based on 2 large prospective randomized trial)

bDiscuss the multi-center trial results that demonstrate that sunitinib, a multi-targeted TKI may delay disease progression in patients with pancreatic neuroendocrine tumors and contribute to increased survival

bUtilize the prognostic value of 8 molecular markers on relapse-free survival and stages II and III colon cancer.

bDefine the benefit for specific subgroups of stage III colon cancer with only 3 months of adjuvant chemotherapy (rather than the standard 6 months).

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

The 2018 Gastrointestinal Oncology Conference will be held at The Hilton Crystal City hotel in Arlington, VA is conveniently located in the heart of Arlington's Crystal City. The hotel is just steps from the Crystal City Metro Station and approximately 1 mile from Ronald Reagan National Airport.

If you require accommodations, a limited number of rooms have been held for the conference at a discounted rate of $195 single/double per night plus applicable taxes. Contact the hotel directly at 800-695-7551 to reserve your room.

IMPORTANT: Be sure to mention the ISGIO Annual Meeting to receive the discounted hotel room rate.

Hilton Crystal City

Hilton Crystal City at Washington Reagan National Airport

2399 Jefferson Davis Highway

Arlington, VA 22202

TEL: +1-703-418-6800

Submission Info

ISGIO invites all participants to submit abstracts describing original work to the 2018 Conference Organizing Committee.

Abstracts must be written in English and begin with a concise Title followed by a list of all Authors and their respective Affiliations. The body of the abstract should not exceed 500 words and must contain the following labeled sections: 

Background, including a statement of the hypothesis or research question;

Methods, an explanation of the study design and experimental methods used;

Results, a summary of the major findings; and

Conclusions, a summary of the overall findings and implications of the results.

E-mail all materials and contact information (full name, affiliation, mailing address, phone, fax and e-mail address) no later than midnight September 3, 2018, to donna.ogilvie@isgio.org.

Approved authors will be notified the week of September 10, 2018.

The ISGIO is pleased to offer a limited number of scholarships (up to $500) to young investigators and fellows to attend the Conference.  Registration Fee, meeting materials, poster session and refreshments are complimentary with the scholarship.

To qualify for the educational scholarship, you must submit a request in writing to the 2018 Conference Organizing Committee, along with:

A data-driven abstract on clinical or basic science regarding GI cancer.

Disclosure Form (please complete and return)

Abstracts must be written in English and begin with a concise Title followed by a list of all Authors and their respective Affiliations. The body of the abstract should not exceed 500 words and must contain the following labeled sections:

Background, including a statement of the hypothesis or research question;

Methods, an explanation of the study design and experimental methods used;

Results, a summary of the major findings; and

Conclusions, a summary of the overall findings and implications of the results.

E-mail all materials, Disclosure Form and contact information (full name, affiliation, mailing address, phone, fax and e-mail address) no later than midnight September 3, 2018, to donna.ogilvie@isgio.org. We apologize, but requests submitted after the deadline will not be considered.

Those individuals who are awarded an educational scholarship will be notified the week of September 10, 2018.

International Society of Gastrointestinal Oncology

200 Broadhollow Road

Suite 207 

Melville, NY 11747

Telephone/Fax

Phone: 631-390-8390

Fax: 631-498-1127